Integration of new or experimental treatment options and new approaches to clinical trials
- PMID: 16239234
- DOI: 10.1093/annonc/mdi964
Integration of new or experimental treatment options and new approaches to clinical trials
Similar articles
-
Clinical trials in ovarian carcinoma: study methodology.Ann Oncol. 2005;16 Suppl 8:viii20-viii29. doi: 10.1093/annonc/mdi963. Ann Oncol. 2005. PMID: 16239233 No abstract available.
-
Specific keynote: clinical trial design problems in ovarian cancer.Gynecol Oncol. 2003 Jan;88(1 Pt 2):S117-21; discussion S122-3. doi: 10.1006/gyno.2002.6698. Gynecol Oncol. 2003. PMID: 12586100 Review. No abstract available.
-
Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens.Ann Oncol. 2005;16 Suppl 8:viii13-viii19. doi: 10.1093/annonc/mdi962. Ann Oncol. 2005. PMID: 16239232 No abstract available.
-
Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer.Eur J Cancer. 2011 Sep;47 Suppl 3:S104-15. doi: 10.1016/S0959-8049(11)70154-X. Eur J Cancer. 2011. PMID: 21943964 Review.
-
Update on relapsed ovarian cancer treatment: from new consensus to daily clinical practice.Future Oncol. 2017 Oct;13(23s):3-9. doi: 10.2217/fon-2017-0316. Epub 2017 Oct 11. Future Oncol. 2017. PMID: 29020819
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical